Twist Bioscience Is Bent, Not Broken: Near-Term Strain, Long-Term Strength (NASDAQ:TWST)

Twist Bioscience now appears more reasonably priced, which should lead to solid returns as fundamentals recover in H2 FY26. Read my latest update on TWST stock.

You will be redirected in 10 seconds.